Document:

Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT
(the “Agreement”), is made and entered into effective as of January 1, 2019 (the “Effective Date”),
by and between Guardion Health Sciences, Inc. (the “Company”) and Michael Favish (the “Executive”).

 

WHEREAS, Executive
currently serves as the Company’s President and Chief Executive Officer;

 

WHEREAS, the Company
is pursuing an initial public offering (“IPO”) and has filed a Registration Statement on Form S-1, as amended,
with the United States Securities and Exchange Commission (the “SEC”);

 

WHEREAS, the Company
wishes to continue to receive the services of Executive for the period provided in this Agreement and Executive is willing to serve
in the employ of the Company upon the terms and conditions hereinafter provided; and

 

NOW, THEREFORE, in
consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto agree as follows:

 

1.           Employment.
The Company hereby agrees to employ Executive and Executive hereby accepts such continued employment by the Company upon the terms
and conditions herein provided.

 

2.           Position
and Responsibilities. During the period of his employment hereunder, Executive agrees to serve the Company in the position
of its President and Chief Executive Officer, and Chairman of the Board of Directors of the Company (the “Board”),
reporting to the Board, and to be responsible for all aspects of the operations of the Company under the direction of the Board
and such other duties as are consistent with Executive’s position hereunder. Subject to the terms of this Agreement, the
Company may change or modify the position of Executive or his duties at any time during the term hereof in a manner consistent
with his executive status; provided, however, that such changes shall not result in a change in Executive’s
primary duties or reporting relationship.

 

3.           Term
of Employment, Duties and Benefits.

 

(A)        Term.
The term of Executive’s employment under this Agreement (the “Term”) shall be three (3) years from the
Effective Date. Absent a written agreement to the contrary, Executive’s continued employment during the Term and following
the expiration of the Term shall be on an “at-will” basis, and such post-Term employment will be subject to termination
by either party at any time, with or without cause or prior notice.

 

(B)         Full-Time
Employment; Travel. Executive shall devote his full business time and attention to the performance of his duties as set forth
in Section 2 of this Agreement and shall not engage in any other business activity or occupation during the Term without the Company’s
prior written consent; provided, however, that nothing contained herein shall prohibit Executive from (i) making
passive investments in privately held or publicly traded companies, provided that Executive shall not own, of record or beneficially,
more than five percent (5%) of the outstanding securities of any such company without the Board’s consent, which shall not
be unreasonably withheld, or (ii) engaging in any employment, consulting, or other outside business activity (“Outside
Activities”) set forth on Exhibit 1. Executive’s participation or membership on any outside boards not referenced
herein shall be prohibited unless expressly consented to by the Company in writing, which consent shall not be unreasonably withheld.
Notwithstanding the foregoing, Executive may serve and participate on charitable or civic boards and endeavors, provided such activities
and permitted activities described in the immediately preceding sentence do not materially interfere with Executive’s duties
to the Company. Executive acknowledges that he shall be required to travel, as reasonably required by the Company, with the reasonable
expenses related to travel being paid or reimbursed by the Company in accordance with its policies regarding reimbursable expenses
adopted from time to time and in accordance with the rules and regulations of the Internal Revenue Code.

 

    	 	-1-	 

     

    

 

(C)         Vacation
and Sick Leave. Executive shall be entitled to sick leave consistent with Company policies in existence and published from
time to time. During each year of the Term, Executive shall accrue paid vacation days at a rate of thirty (30) days per year, the
unused amount of which shall carry over and continue to accrue until Executive has accrued forty-five (45) paid vacation days.
Once the maximum number of days has been accrued, Executive shall cease continuing to accrue paid vacation days until the unused
number of days falls below the maximum. Accrued but unused vacation days shall be paid to Executive upon the separation of Executive’s
employment.

 

(D)         Employee
Benefits. The Company shall provide Executive with customary benefits, including medical insurance and participation in disability
and retirement plans, subject to the terms and conditions of the applicable plans, in each case equivalent to, and only to the
extent, that such benefits are provided to other senior executives of the Company.

 

(E)         Business
and Entertainment Expenses. Upon presentation of appropriate documentation, Executive shall be reimbursed in accordance with
Company policy applicable to senior executives for the reimbursement of expenses for all reasonable and necessary business and
entertainment expenses incurred in connection the performance of his duties hereunder. The Company will pay directly or reimburse
Executive for his reasonable attorneys’ fees and costs incurred in connection with the negotiation and implementation of
this Agreement, in an amount not to exceed $7,500.

 

4.           Compensation.

 

(A)        Salary.
Commencing on the Effective Date, and except as otherwise provided herein, for all services rendered by Executive in any capacity
during his employment under this Agreement, including, without limitation, services as an executive or officer of the Company,
related companies or subsidiaries of the Company, the Company shall pay Executive, a gross salary (“Salary”)
at an annualized rate of Three Hundred Thousand Dollars ($300,000) for calendar year 2019. Thereafter, Executive’s Salary
shall increase to Three Hundred Twenty Five Thousand ($325,000) for calendar year 2020 and Three Hundred Fifty Thousand ($350,000)
for calendar year 2021. Salary payments shall be subject to deductions and withholdings required by law and otherwise authorized
by Executive for his participation in employee benefit plans, and shall be payable in equal installments in accordance with the
Company’s standard payroll practices (but no less frequently than monthly).

 

(B)         Stock
Option. The Company shall grant Executive a non-qualified stock option to purchase 1,250,000 shares (as calculated after any
reverse split of the Company’s common stock effectuated in anticipation of the IPO (i.e., currently, prior to such split,
the number of shares is 2,500,000)) of the Company’s common stock (the “Option”). The date of grant of
the Option (the “Grant Date”) shall be the date of and immediately after the Company closes its IPO and sells
its shares to the public. The Option term shall be five (5) years from the Grant Date and the Option shall have a purchase price
per common share equal to 110% of the final IPO price per common share. The Option shall vest ratably over three (3) years commencing
on March 31, 2019 (if the IPO has closed prior to such date, or otherwise on the first calendar quarter end date following the
Grant Date), and at the end of each calendar quarter thereafter until fully vested, provided that, subject to Section 8 below,
vesting will depend on Executive’s continued employment with the Company on the applicable vesting dates, and will be subject
to the terms and conditions of the written agreement governing the grant and this Agreement. The Company agrees to register the
shares subject to the Option with the SEC under a Registration Statement on Form S-8, or other appropriate form of registration
statement, and the Executive agrees to enter into a customary form of option agreement with the Company incorporating the provisions
contained in this Section 4(B) and other customary terms and conditions.

 

    	 	-2-	 

     

    

 

(C)         Bonus.
In addition to the Salary and the Option, Executive shall be eligible for an annual bonus. Executive’s initial annual bonus
target will be 100% of Executive’s Salary for the applicable calendar year (the “Target Bonus”), and the
actual bonus amount awarded (the “Actual Bonus”) will be 50% based on the achievement of Company financial and
other performance metrics determined by the Board and communicated to Executive from time to time, and 50% as determined by the
Board, in its sole discretion. To earn any Actual Bonus, Executive must be employed by the Company on the payment date of the Actual
Bonus. The Actual Bonus shall be paid no later than March 15 of the year following the year to which the performance objectives
relate. Executive’s bonus participation will be subject to all the terms, conditions and restrictions of the applicable Company
bonus plan or program, if any, as may be amended from time to time, but only to the extent such plan or program is consistent with
this Agreement.

 

5.           Termination.
Executive’s employment and the Term shall terminate on the first of the following to occur:

 

(A)        Disability.
Upon written notice by the Company to Executive of termination due to Disability. For purposes of this Agreement, “Disability”
shall be defined as the inability of Executive to perform his material duties hereunder due to a physical or mental injury, infirmity
or incapacity for 120 days (including weekends and holidays) in any 365-day period or for 60 consecutive days with reasonable accommodations
as defined, and if required, by applicable state and federal disability laws. To the extent necessary, the existence or nonexistence
of a Disability shall be determined by an independent physician selected by the Company and reasonably acceptable to Executive.

 

(B)         Death.
Automatically on the date of death of Executive.

 

(C)         Cause.
For Cause. “Cause” shall mean a reasonable determination by the Board that Executive has committed, or there
has occurred, one or more of the following:

 

(i)         Executive’s
indictment for a felony or another crime involving serious moral turpitude;

 

(ii)        Executive’s
conviction of, a guilty plea with respect to, or a plea of nolo contendere to a crime involving fraud, theft, embezzlement, any
other crime that results in or is intended to result in personal enrichment at the expense of the Company or any other summary
offense that will, in the opinion of the Company, adversely affect in any material respect the Company’s prospects or reputation
or Executive’s ability to perform his obligations or duties to the Company;

 

(iii)       Executive’s
material breach of this Agreement or any of the Company’s policies;

 

(iv)       Executive’s
intentional and continual failure to substantially perform his reasonably assigned duties with the Company (other than a failure
resulting from Executive’s incapacity due to Disability or from the assignment to Executive of duties that would constitute
Good Reason); and

 

    	 	-3-	 

     

    

 

(v)       Executive’s
commission or cooperation in an act of fraud, theft, or dishonesty against the Company, or any act or omission intended to result
in the personal enrichment of Executive or a personal relation of Executive, in violation of Executive’s duty of loyalty
to the Company at the expense, directly or indirectly, of the Company.

 

provided,
however, that with respect to sections (iii) or (iv) above, a written notice of demand for substantial performance has been
delivered to Executive by the Company, which demand for performance must be made within ninety (90) days after the initial occurrence
of the event or latest in a series of events which constitutes “Cause”, and such notice must provide reasonable notification
of the conduct giving rise to “Cause”, to the extent capable of cure, and Executive fails to cure such circumstance
for a period of thirty (30) days (which cure right shall not be available to the extent the Executive previously cured a similar
event) (or such longer period as may be reasonable under the circumstances provided Executive is working in good faith on such
cure, and further provided that the total cure period shall not exceed ninety (90) days), and in all respects Executive is given
an opportunity to make a presentation to the Board regarding the event giving rise to Cause.

 

(D)         Good
Reason. The Executive’s resignation during a period not to exceed ninety (90) days following the initial existence of
one or more of the events listed below, provided that Executive gives the Company written notice not more than thirty (30) days
after the initial occurrence of the applicable event or events listed below that Executive intends to terminate his employment
hereunder due to such event or events and provided further that such events are not corrected in all material respects by the Company
within thirty (30) days following such written notice (or such longer period as may be reasonable under the circumstances provided
Executive is working in good faith on such cure, and further provided that the total cure period shall not exceed ninety (90) days).
“Good Reason” shall mean, without the written consent of Executive, the occurrence of any one or more of the
following events:

 

(i)        A
material diminution in Executive’s authority, duties or responsibilities as contemplated by this Agreement (it being understood
that a mere change in Executive’s title following a change of control of the Company, such as might occur if the Company
were acquired and became a division of a larger company, shall not constitute a material diminution in the Executive’s authority),
duties or responsibilities;

 

(ii)        any
material breach by the Company of its obligations under this Agreement;

 

(iii)       the
relocation or transfer of Executive’s office outside a 50 mile radius of the Company office that Executive had been working
in; or

 

(iv)      a
material reduction in Executive’s Salary, or the elimination of his eligibility for payments under a Bonus.

 

    	 	-4-	 

     

    

 

(E)         Change
in Control Termination. A “Change in Control Termination” shall occur in the event a Change in Control occurs
and if the Company terminates Executive’s employment without Cause or if Executive resigns for Good Reason, in either case,
within the period beginning one (1) month before, and three (3) months following, such Change in Control. ”Change
in Control” shall occur upon (i) any “Person” (as such term is used in Sections 13(d) and 14(d) of
the Exchange Act) becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly,
of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company’s
then-outstanding voting securities; (ii) the consummation of the sale or disposition by the Company of all or substantially
all of the Company’s assets; (iii) the consummation of a merger or consolidation of the Company with any other corporation,
other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto
continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or
its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such
surviving entity or its parent outstanding immediately after such merger or consolidation; or (iv) a change in the effective
control of the Company that occurs on the date that a majority of members of the Board is replaced during any twelve (12) month
period by members of the Board whose appointment or election is not endorsed by a majority of the members of the Board prior to
the date of the appointment or election. For purposes of this definition, Persons will be considered to be acting as a group if
they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business
transaction with the Company; provided that Change in Control shall not be deemed to occur unless such event is also a change in
the ownership or effective control of the Company, or in the ownership of a substantial portion of the assets of the Company within
the meaning of Section 409A, as defined below. An IPO shall not be deemed a Change in Control.

 

6.           Consequences
of Termination. Any termination payments made and benefits provided under this Agreement to Executive shall be as described
herein, and Executive shall not be eligible for any additional severance under any of the plans, policies or programs of the Company.
Immediately upon termination of employment, Executive shall return to the Company all Company property used by Executive including,
without limitation, any computer or laptop, cell phone, or portable electronic devices, as well as all other Company property in
Executive’s possession, custody or control, regardless of form or medium. Subject to Section 18, the following amounts and
benefits shall be due to Executive:

 

(A)        Disability.
Upon termination of Executive due to Disability, the Company shall pay or provide Executive: (i) any unpaid Salary through
the date of termination and any accrued vacation in accordance with Company policy; (ii) reimbursement for any unreimbursed
expenses incurred through the date of termination; and (iii) any payments due under the Bonus as described in Section 4(c); and
(iv) as and when due thereunder, all other payments, benefits or fringe benefits to which Executive may be entitled under
the terms of any applicable compensation arrangement or benefit, equity or fringe benefit plan or program or grant or this Agreement
(collectively, the “Accrued Amounts”).

 

(B)         Death.
In the event of the death of Executive, Executive’s estate shall be entitled to any Accrued Amounts.

 

(C)         Termination
for Cause or Resignation Without Good Reason. If Executive’s employment should be terminated (i) by the Company
for Cause, or (ii) by Executive without Good Reason, the Company shall pay Executive any Accrued Amounts. The unvested Option
shall terminate and the Executive shall have ninety (90) days to exercise his vested Option. Except as set forth in this Section
6(C), all of Executive’s rights to compensation and any other rights to payment under this Agreement shall terminate upon
the date of the termination of Executive’s employment with the Company, except for the rights of Executive to any indemnification
and director and officer insurance coverage.

 

(D)         Termination
without Cause or Resignation for Good Reason. If the Company terminates Executive’s employment other than in conformity
with Sections 5(A), 5(B) or 5(C) above, or if Executive terminates his employment for Good Reason, the Company shall pay Executive
the Accrued Amounts (and the unvested Option shall continue in full force and effect under its terms) and, additionally, subject
to (x) Executive’s immediate return to the Company of all Company property, and (y) Executive’s execution
and non-revocation of a waiver and release of claims agreement in a form reasonably satisfactory to the Company (a “Release”)
in accordance with Section 18(C), the Company shall pay as a lump sum the prorated (based on the number of days Executive was employed
during the calendar year) Bonus that would have been paid for the year of termination and any bonus for the year preceding termination,
to the extent unpaid (with such Bonus being measured and payable as set forth in Section 4(C) above), and in addition:

 

    	 	-5-	 

     

    

 

(i)         during
the one (1) year period immediately following the termination of Executive’s employment (the “Severance Period”)
pay to Executive an amount (the “Severance Payment”) equal to, in the aggregate, one (1) year (two (2) years,
in the event of a Change in Control Termination) of Executive’s annual salary for the year in which such termination occurs,
which Severance Payment shall be payable in equal installments during the Severance Period, at the same time and in the same manner
as Executive’s salary would have been paid had Executive remained in active employment during the Severance Period, in accordance
with the Company’s standard payroll practices as in effect on the date of such termination; provided that in the event of
a Change in Control Termination (1) if such terminations occurs after the date of the Change in Control, the Severance Payment
shall be paid in lump sum and (2) if such termination is prior to the Change in Control, half of the Severance Payment shall be
paid in lump sum and the remainder shall be paid over the Severance Period.

 

(ii)        Solely
in connection with a Change in Control Termination, with respect to the Option and any other outstanding equity awards time vesting
(but not performance vesting, if any) shall accelerate and become vested and exercisable as to 100% of the then-unvested shares
subject to the Option and other equity awards effective on the date that the Release becomes irrevocable and Executive shall have
360 days to exercise the Option (or, if earlier, until the expiration of the original term of the Option).

 

(iii)       During
the Severance Period and for an additional one (1) year, in case of Change in Control Termination, subject to Executive’s
timely election of continued coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”),
provide access to continued coverage under the Company’s medical plan for Executive, and his eligible dependents (the “COBRA
Severance Benefits”); provided that Executive shall pay to the Company, on an after-tax basis, a monthly amount equal
to the full premium cost of the COBRA Severance Benefits (determined in accordance with the methodology under COBRA, or such other
methodology as required by the Internal Revenue Service under Section 105(h) of the Code) for such month and, within thirty (30)
days of the end of each month during which Executive has COBRA coverage during the Severance Period (the “COBRA Benefit
Period”), the Company shall pay Executive in cash (less required withholding) a taxable amount equal to the sum of  the
excess of (x) the full premium cost of the COBRA Severance Benefits for such month and (y) any premium amount that would
have been payable by Executive if Executive had been actively employed by the Company for such month (collectively, the “COBRA
Premium Benefits”).

 

Notwithstanding the foregoing, if the Company
determines, in its sole discretion, that the Company cannot provide the COBRA Premium Benefits without potentially incurring financial
costs or penalties under applicable law (including, without limitation, the Patient Protection and Affordable Care Act of 2010,
as amended (the “ACA”)), the Company shall in lieu thereof pay Executive taxable cash amounts equal to the COBRA
Premium Benefits, which payments shall be made regardless of whether the Executive or Executive’s eligible dependents elect
COBRA continuation coverage or pay premiums for continued COBRA coverage (the “Health Care Benefit Payments”)
and shall be made solely if permitted under the ACA and related administrative guidance. The Health Care Benefit Payments shall
be paid to Executive in installments on the same schedule that the COBRA Premium Benefits would otherwise have been paid to Executive
and shall be paid until the expiration of the COBRA Benefit Period.

 

    	 	-6-	 

     

    

 

Executive shall be excused from providing
services to the Company during the Severance Period. Notwithstanding the foregoing, no portion of the Severance Payment shall be
paid nor COBRA Premium Benefits provided pursuant to this Section 6(D) following the date that the Board determines that the Executive
first violates any of the restrictive covenants set forth in Section 7 and, upon such violation, Executive shall within 30 days
of such violation repay the Company all previously paid Severance Payments and COBRA Premiums (less $100). The Company shall have
the right to suspend such payments during the pendency of any proceedings relating to such legal determination provided that any
such suspension is founded upon the Board’s good faith belief that any of the provisions identified herein have been breached.
If legal proceedings determine that Executive committed no such breach, then within five (5) business days following the entry
of a final judgment in any such proceeding, the Company shall pay to Executive all such suspended amounts and any amounts repaid
to the Company by the Executive pursuant to this paragraph, without interest thereon. With respect to the compensation and benefits
due pursuant to this Section 6(D), Executive shall not have any duty to mitigate his income loss by finding alternative employment,
nor shall amounts Executive earns from other employment be offset against such compensation and benefits.

 

(E)         Resignation
from All Positions. Upon the termination of the Executive’s employment with the Company for any reason, the Executive
shall resign, as of the date of termination, from all positions Executive then holds as an officer, director, employee and member
of the Board (and any committee thereof) of the Company and any of its affiliates. The Executive shall be required to execute such
writings as are required to effectuate the foregoing.

 

7.           Restrictive
Covenants.

 

(A)         Confidentiality.
Executive shall not, directly or indirectly, use, make available, sell, disclose or otherwise communicate to any person, other
than in the course of Executive’s assigned duties and for the benefit of the Company, either during the Term or at any time
thereafter, any nonpublic proprietary or confidential information, knowledge or data relating to the Company or any of its affiliates
that has been obtained by Executive during Executive’s employment with the Company or has been obtained pursuant to any consulting
services provided by Executive to the Company or any of its affiliates prior to Executive’s employment with the Company.
For the purposes of this Agreement, nonpublic proprietary information means information proprietary to the Company that is not
generally known (including any “trade secret” within the meaning of applicable laws) about the Company’s customers,
products, services, personnel, pricing, sales strategy, technology, methods, processes, research, development, finances, systems,
techniques, accounting, purchasing and plans. All information disclosed to Executive or to which he obtains access, whether originated
by him or by others, during the period that Executive is an employee of the Company (whether prior to the Effective Date or thereafter),
shall be presumed to be non-public proprietary information if it is so treated by the Company or if Executive has a reasonable
basis to believe it to be such. The foregoing shall not apply to information that (i) was known to the public prior to its
disclosure to Executive; (ii) becomes known to the public subsequent to disclosure to Executive through no wrongful act of
Executive or anyone acting on Executive’s behalf; or (iii) Executive is required to disclose by applicable law, regulation
or legal process (provided that, unless contrary to law, Executive provides the Company with prior notice of the contemplated
disclosure and reasonably cooperates with the Company at its expense in seeking a protective order or other appropriate protection
of such information). Notwithstanding clauses (i) and (ii) of the preceding sentence, Executive’s obligation to maintain
such disclosed information in confidence shall not terminate where only portions of the information are in the public domain.

 

    	 	-7-	 

     

    

 

(B)         Non-Disparagement.
During the Term or at any time thereafter, neither Executive or Company shall make any public statements that disparage the other
party, or in the case of the Company, its respective subsidiaries, affiliates, employees, officers, directors, business, technology,
products or services. Notwithstanding the foregoing, statements made in the course of sworn testimony in administrative, judicial
or arbitral proceedings (including, without limitation, depositions in connection with such proceedings) shall not be subject to
this Section 7(B), and nothing contained herein shall be deemed to prevent any party from rebutting any statement made or written
or from making truthful statements as reasonably necessary to enforce their rights hereunder.

 

(C)         Non-Solicitation.
During the period of Executive’s employment and for one (1) year after the separation thereof, Executive shall not, directly
or indirectly: (i) solicit or encourage any employee or consultant of Company or any of its affiliates to leave the employ or otherwise
cease or reduce work with Company or any affiliate of Company, provided that this provision shall not apply with respect to any
person (a) who responds to a general solicitation not targeted at such individual, or (b) who has terminated his or her employment
with the Company or any of its affiliates more than one hundred eighty (180) days prior to his or her retention by Executive; or
(ii) solicit or encourage any customer (known to Executive) or prospective customer of Company to withdraw, curtail or cancel its
business dealings with the Company. For purposes hereof, a “prospective customer” shall mean any potential customer
with whom the Company conducted discussions about becoming a customer during the six (6) months preceding Executive’s termination,
of which discussions Executive had actual knowledge.

 

(D)         Non-Trading.
Without limiting Executive’s obligations to the Company, Executive shall comply with all rules and regulations of the SEC,
including, without limitation, Section 10(b) and Rule 10b-5 of the Securities Exchange Act of 1934, as amended, (the “1934
Act”) which, among other things, prevents a party in possession of material non-public information from trading in a
company’s securities or causing a third party to trade in a company’s securities that is subject to the 1934 Act.

 

(E)         Exceptions.
Executive may not be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade
secret that (i) is made in confidence to a federal, state, or local government official, either directly or indirectly, or
to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in
a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.

 

(F)         Enforceability.
Executive recognizes and agrees that monetary damages may be an inadequate remedy in the event of any breach of this Section 7,
and that any such breach may cause Company irreparable harm and damage. Accordingly, the parties agree that Company shall be entitled
to injunctive and other equitable relief against Executive without waiving any additional rights or remedies available to it, and
without the necessity of posting a bond. If any provision hereof shall be held invalid, illegal or unenforceable, the remaining
provisions shall continue in full force and effect. If any provisions shall for any reason be held to be excessively broad as to
time, duration, geographical scope, activity or subject, it shall be construed, by limiting and reducing it, so as to be enforceable
to the extent permitted by applicable law.

 

    	 	-8-	 

     

    

 

8.           Proprietary
Rights. Executive agrees that, from the first date of Executive’s performance of services for the Company, all inventions,
discoveries and improvements, whether patentable or unpatentable, and all works of authorship, whether copyrightable or uncopyrightable,
made, developed, conceived, modified, acquired, devised, discovered or created by Executive, whether solely or jointly with others,
whether by using the Company’s or its subsidiaries’, divisions’, affiliates’ or parent’s, equipment,
supplies, facilities, trade secrets, confidential information or otherwise, and which relate to or pertain in any way at the time
of conception or reduction to practice of the invention or of creation of the work of authorship to the business of the Company,
or its subsidiaries, divisions, affiliates or parent, or the actual, or demonstrably anticipated research or development of the
Company, or its subsidiaries, divisions, affiliates, or parent, or which result from any work performed by Executive for the Company,
or its subsidiaries, divisions, affiliates or parent (hereinafter “Inventions”), shall be promptly disclosed
in writing by Executive to the Company, and shall be the exclusive property of the Company or its assignee. Executive acknowledges
that all Inventions shall be deemed and considered “Works for Hire” under the copyright laws of the United States;
and moreover, that all right, title and interest therein, including all rights of copyright, patent or otherwise, in the United
States and in all foreign countries, in any form or medium and in all fields of use now known or hereafter existing, shall belong
exclusively to the Company. Executive further acknowledges that the Company is under no obligation to Executive, monetary or otherwise,
in connection with such Works for Hire, except for indemnity rights that Executive shall be entitled to arising out of Company’s
use of such Works for Hire. To the extent an assignment is necessary to perfect the Company’s ownership of any Invention
or Work for Hire described in this Section, Executive hereby irrevocably assigns to the Company or its assignee, all of his right,
title and interest therein, and agrees that neither the Company, nor its subsidiaries, divisions, affiliates or parent, are under
further obligation, monetary or otherwise, to Executive for such assignment. Executive agrees to execute, acknowledge and deliver
to the Company, its successors and assigns, both during and after his employment, all documentation, including, but not limited
to, applications for patents and/or copyrights, as the Company may deem necessary or desirable to obtain and perfect the interests
of the Company, its successors and assigns, in any and all countries, in such Inventions and/or Works for Hire, and to vest title
thereto in the Company. Pursuant to California Labor Code Section 2872, this covenant shall not apply to an invention that qualifies
under the provisions of Section 2870 of the California Labor Code, as explained in the Invention Assignment Notice attached hereto
as Exhibit 2. Further, Executive acknowledges that all unpatented inventions, discoveries, improvements, or works of authorship
which were owned and controlled by him on the initial date of Executive’s performance of services for the Company have been
listed on the Prior Employment Agreement or on Exhibit 3 and are the property of Executive. In the event that Executive
(a) refuses to perform any act necessary to obtain any copyrights or patents as required by this Agreement or (b) Executive
is unavailable within the meaning of the United States patent and copyright laws, Executive irrevocably appoints any Company-selected
designee to act, at all times hereafter, as Executive’s agent and attorney-in-fact to perform those acts, said appointment
being deemed coupled with an interest.

 

9.           Survivors
Bound. This Agreement shall be binding upon and inure to the benefit of the parties hereto, the legal representatives, successors
in interest and assigns, respectively, of each party.

 

10.         Insurance.
The Company is authorized to purchase, own and be the beneficiary of a policy of insurance of the life of Executive in such amounts
as the Company may elect to compensate the Company for the loss of Executive. If requested by the Company, Executive shall submit
to such examinations as may be prescribed by the Company’s insurer in furtherance of such application for insurance.

 

11.         Trading
Plan. Executive shall be permitted to enter into a Rule 10b5-1 compliant trading plan beginning one (1) year after the completion
of the IPO.

 

12.         Indemnification;
Director’s and Officer’s Liability Insurance. Executive shall have all rights to indemnification to the fullest
extent permitted by Delaware law (to the extent not prohibited by the Company’s Certificate of Incorporation or Bylaws as
currently in effect) for any actions or inactions as an officer or director of the Company or any related entity and as a fiduciary
of any benefit plan of any of the foregoing. In addition, the Company shall use reasonable efforts to maintain Director’s
and Officer’s liability insurance on behalf of Executive, at least until the end of the Term, and throughout the period of
any applicable statute of limitations, in an amount and on terms at least as favorable to Executive as provided by the Company
or its affiliates to any current or former officer or director.

 

    	 	-9-	 

     

    

 

13.         Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of California without giving
effect to such state’s principles of conflicts of laws.

 

14.         Waiver.
The waiver by either party hereto of any breach of any provision of this Agreement shall not operate or be construed as a waiver
or any subsequent breach by either party hereto.

 

15.         Binding
Effect and Assignment. This Agreement shall be binding upon and inure to the benefit of the Company, its successors and assigns,
and Executive. This Agreement is personal as to Executive and may not be assigned by Executive without first obtaining the written
consent of the Company. This Agreement may be not assigned by the Company without the prior consent of Executive except to a successor
in interest to the Company.

 

16.         Severability.
The unenforceability of any provision or provisions of this Agreement shall not affect the enforceability of any other provision
of this Agreement.

 

17.         Entire
Understanding. Unless otherwise expressly stated herein, this Agreement contains the entire understanding of the parties relating
to the employment of Executive by the Company and may not be contradicted by evidence of any prior or contemporaneous agreement
or any other term sheets, employment agreements or related written agreements or oral understandings between the Company and Executive
relating to the terms and conditions of Executive’s employment with the Company, which the parties hereby acknowledge and
agree shall be superseded in their entirety by this Agreement. This Agreement may be changed only by an agreement in writing signed
by the party or parties against whom enforcement of any waiver, change, modification, extension or discharge is sought.

 

18.         Amendment
and Default. This Agreement may be amended in whole or part at any time and from time to time but only in writing in a form
substantially similar to the form hereof. In the event of default or breach of any of the terms and conditions hereof the defaulting
party agrees to pay the reasonable attorney’s fees incurred by the other party in enforcing the provisions hereof.

 

19.         Section
409A and Release.

 

(A)         General.
The intent of the parties is that all payments and benefits under this Agreement comply or are exempt from Section 409A of the
Internal Revenue Code of 1986, as amended (the “Code”) and the regulations and guidance promulgated thereunder
(“Section 409A”). The parties hereto acknowledge and agree that, to the extent applicable, and to the extent
that any term or provision is ambiguous, this Agreement shall be interpreted in accordance with, and incorporate the terms and
conditions required by, Section 409A of the Code and the Department of Treasury Regulations and other interpretive guidance issued
thereunder. No provision of this Agreement shall be interpreted or construed to transfer any liability for failure to comply with
the requirements of Section 409A from Executive or any other individual to the Company or any of its affiliates, employees or agents.

 

(B)         Separation
from Service under Section 409A. Notwithstanding any provision to the contrary in this Agreement:

 

(i)         no
amount that is “nonqualified deferred compensation” for purposes of Section 409A shall be payable pursuant to Section
6(D) unless the termination of Executive’s employment constitutes a “separation from service” within the meaning
of Section 1.409A-1(h) of the Department of Treasury Regulations;

 

    	 	-10-	 

     

    

 

(ii)        if
Executive is deemed at the time of his separation from service to be a “specified employee” for purposes of Section
409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the termination benefits to which Executive
is entitled under this Agreement (after taking into account all exclusions applicable to such termination benefits under Section
409A, including, without limitation, exclusions for separate installment payments and exclusions under Section 1.409A-1(b)(9)(iii)
of the Department of Treasury Regulations) is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i)
of the Code, such portion of Executive’s termination benefits shall not be provided to Executive prior to the earlier of
(x) the expiration of the six-month period measured from the date of Executive’s separation from service with the Company
or (y) the date of Executive’s death. Upon the earlier of such dates, all payments deferred pursuant to this Section
18(B)(ii) shall be paid in a lump sum to Executive, and any remaining payments due under this Agreement shall be paid as otherwise
provided herein;

 

(iii)       the
determination of whether Executive is a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code as
of the time of his separation from service shall be made by the Company in accordance with the terms of Section 409A of the Code
and applicable guidance thereunder (including without limitation Section 1.409A-1(i) of the Department of Treasury Regulations
and any successor provision thereto);

 

(iv)       for
purposes of Section 409A, Executive’s right to receive installment payments pursuant to Section 6(D) shall be treated as
a right to receive a series of separate and distinct payments as described in Treasury Regulation Section 1.409A(2)(b)(2); and

 

(v)        to
the extent that any reimbursement of expenses or in-kind benefits constitutes “deferred compensation” under Section
409A, such reimbursement or benefit shall be provided no later than December 31 of the year following the year in which the
expense was incurred. The amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any
subsequent year. The amount of any in-kind benefits provided in one year shall not affect the amount of in-kind benefits provided
in any other year.

 

(C)         Release.
The following provisions shall apply notwithstanding anything to the contrary in this Agreement. The Company shall deliver the
Release to Executive within seven (7) days following the date of termination of employment. Executive shall have until the date
that is twenty-one (21) days (or such later date as is required by applicable law) following the date upon which the Company timely
delivers the Release to Executive (the expiration of such applicable period, the “Release Deadline”) to execute the
Release. Executive shall have seven (7) days following the execution of the Release to revoke the Release. If the execution and
revocation period crosses calendar years, Company shall commence payments on the first Payroll Date in the second calendar year
(with the first payment containing all of the payments which should have been paid, but were not paid, prior to such date).

 

    	 	-11-	 

     

    

 

20.         Mutual
Binding Arbitration. It is agreed that any and all disputes, claims or controversies arising out of or relating to this Agreement
or to Executive’s employment by the Company shall be resolved exclusively by binding arbitration administered by JAMS pursuant
to its Employment Arbitration Rules & Procedures in effect at the time the dispute is submitted (currently available at http://www.jamsadr.com/rules-employment-arbitration/).
The Company and Executive agree that this arbitration provision is governed by the Federal Arbitration Act, 9 U.S.C. §§
1, et seq. The Company and Executive also understand and agree that the Company is engaged in transactions involving interstate
commerce. The arbitration proceedings will be held before a single, neutral arbitrator in the County of San Diego, State of California.
The fees of the arbitrator and all other costs that are unique to the arbitration process shall be paid by the Company to the extent
required by law. Otherwise, each party shall be solely responsible for paying its own costs for the arbitration, including but
not limited to attorneys’ fees. However, if either party prevails on a claim which affords the prevailing party attorneys’
fees pursuant to law, statute, or contract, the arbitrator may award reasonable attorneys’ fees to the prevailing party.
The arbitrator shall apply state and/or federal substantive law to determine issues of liability and damages regarding all claims
to be arbitrated. The arbitrator shall have the authority to order such discovery, by way of deposition, interrogatory, document
production, or otherwise, as the arbitrator considers necessary to a full and fair exploration of the issues in dispute, consistent
with the expedited nature of arbitration. The award of the arbitrator shall be in writing and shall contain the arbitrator’s
factual findings, legal conclusions and reasons for the award. The following actions are excluded from this provision: (i) claims
for workers’ compensation benefits; (ii) claims for unemployment insurance compensation benefits; and (iii) to
the extent required by law, administrative claims or charges before applicable federal and state administrative agencies (such
as the Equal Employment Opportunity Commission or comparable state agency, and any unfair labor charge which is to be brought under
the National Labor Relations Act). The arbitrator shall have the authority to award any individual damages or relief authorized
by law. Arbitration must be demanded within the statute of limitations governing the claims at issue. The award may be entered
as a judgment in any court with jurisdiction over Company or Executive.

 

21.         Counterparts.
This Agreement may be executed in one or more counterparts, which may be delivered by electronic means (including by means of facsimile
or email), each of which shall be deemed an original but all of which together shall constitute one and the same instrument.

 

22.         Approval.
The Board of the Company has approved this Agreement, including the terms of the grant of the Option, and the resolution of the
Board provides that any member of the Board is authorized to execute and deliver this Agreement on behalf of the Company.

 

*         *         *

 

[Signatures to appear on the following page.]

 

    	 	-12-	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto are duly authorized to execute this Agreement and have executed this Agreement, effective as of the Effective
Date.

 

	 	GUARDION HEALTH SCIENCES, INC.
	 	 
	 	By:	/s/ Robert Weingarten
	 	 	 
	 	Name:	Robert Weingarten
	 	 	 
	 	Title:	Director
	 	 	 
	 	Date:	12/21/2018
	 	 
	 	EXECUTIVE
	 	 
	 	/s/ Michael Favish
	 	Michael Favish
	 	 
	 	Date:	 12/21/2018

 

    	 	-13-	 

     

    

 

EXHIBIT 1

 

OUTSIDE ACTIVITIES

 

None

 

    	 	-14-	 

     

    

 

EXHIBIT 2

 

INVENTION ASSIGNMENT NOTICE

 

In accordance with
Section 2872 of the California Labor Code, you are hereby notified that the invention assignment provisions of the Employment Agreement
which you have signed do not apply to an invention which qualifies fully under the provisions of Section 2870 of the California
Labor Code, which provides in pertinent part:

 

Any provision in an employment
agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or
her employer shall not apply to an invention which was developed entirely on his or her own time without using the employer’s
equipment, supplies, facilities or trade secret information except for those inventions that either:

 

(1)          Relate
at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably
anticipated research or development of the employer, or

 

(2)          Result
from any work performed by the employee for the employer.

 

RECEIPT ACKNOWLEDGED

 

	Signed:	 /s/ Michael Favish	 	Dated:	December 21, 2018

 

    	 	-15-	 

     

    

 

EXHIBIT 2

 

EXCLUDED INVENTIONS, DISCOVERIES, WORKS
OF AUTHORSHIP,

AND WORKS FOR HIRE

 

None

 

	Signed:	/s/ Michael Favish	 	Dated:	December 21, 2018

 

    	 	-16-job_ex1082.htm

EXHIBIT 10.82
  
 FOURTH AMENDMENT
 TO REVOLVING CREDIT, TERM LOAN 
 AND SECURITY AGREEMENT
  
 FOURTH AMENDMENT, dated as of December 27, 2018 (this "Amendment"), to the Revolving Credit, Term Loan and Security Agreement, dated as of March 31, 2017 (as amended, amended and restated, restated, supplemented or otherwise modified from time to time, the "Credit Agreement"), by and among GEE GROUP INC., an Illinois corporation ("Holdings"), SCRIBE SOLUTIONS, INC., a Florida corporation ("Scribe"), AGILE RESOURCES, INC., a Georgia corporation ("Agile"), ACCESS DATA CONSULTING CORPORATION, a Colorado corporation ("Access"), TRIAD PERSONNEL SERVICES, INC., an Illinois corporation ("Triad Personnel"), TRIAD LOGISTICS, INC., an Ohio corporation ("Triad Logistics"), PALADIN CONSULTING, INC., a Texas corporation ("Paladin"), BMCH, INC., an Ohio corporation ("BMCH"), GEE GROUP PORTFOLIO INC., a Delaware corporation and the surviving corporation of the merger of SNI HOLDCO INC., a Delaware corporation, with and into GEE Group Portfolio Inc., a Delaware corporation ("SNI Holdings"), and SNI COMPANIES, a Delaware corporation ("SNI" and together with Holdings, Scribe, Agile, Access, Triad Personnel, Triad Logistics, Paladin, BMCH, SNI Holdings and each other Person joined thereto as a borrower from time to time, collectively, the "Borrowers" and each a "Borrower"), each Subsidiary of Holdings listed as a "Guarantor" on the signature pages thereto (together with each other Person joined thereto as a guarantor from time to time, collectively, the "Guarantors", and each a "Guarantor", and together with the Borrowers, collectively, the "Loan Parties" and each a "Loan Party"), the lenders which now are or which thereafter become a party thereto that make Revolving Advances thereunder (together with their respective successors and assigns, collectively, the "Revolving Lenders" and each a "Revolving Lender"), the lenders which now are or which thereafter become a party thereto that made or acquire an interest in the Term Loans (together with their respective successors and assigns, collectively, the "Term Loan Lenders" and each a "Term Loan Lender", and together with the Revolving Lenders, collectively, the "Lenders" and each a "Lender"), MGG INVESTMENT GROUP LP ("MGG"), as administrative agent for the Lenders (together with its successors and assigns, in such capacity, the "Administrative Agent"), as collateral agent for the Lenders (together with its successors and assigns, in such capacity, the "Collateral Agent"), and as term loan agent (together with its successors and assigns, in such capacity, the "Term Loan Agent" and together with the Administrative Agent and the Collateral Agent, each an "Agent" and, collectively, the "Agents").
  
 WHEREAS, the Loan Parties, the Agents and the Lenders are parties to the Credit Agreement, pursuant to which the Lenders have made and may hereafter make certain loans and have provided and may hereafter provide certain other financial accommodations to the Borrowers;
  
 WHEREAS, the Loan Parties have requested that the Agents and the Lenders amend certain terms and conditions of the Credit Agreement; and 
  
 WHEREAS, the Agents and the Lenders are willing to amend such terms and conditions of the Credit Agreement on the terms and conditions set forth herein.
  
  	 
	1
	 
 
	 

  
 NOW THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
  
 1. Definitions. All terms used herein that are defined in the Credit Agreement and not otherwise defined herein shall have the meanings assigned to them in the Credit Agreement. 
  
 2. Amendments. 
  
 (a) New Definitions. Section 1.2 of the Credit Agreement is hereby amended by adding the following definitions, in appropriate alphabetical order:
  
 (i) ""Amendment No. 4" shall mean the Fourth Amendment to Revolving Credit, Term Loan and Security Agreement, dated as of December 27, 2018, by and among the Loan Parties, the Agents and the Lenders."
  
 (ii) ""Amendment No. 4 Effective Date" shall mean the 'Amendment No. 4 Effective Date' as set forth in Amendment No. 4."
  
 (b) Existing Definitions. Section 1.2 of the Credit Agreement is hereby amended as follows:
  
 (i) "EBITDA" is hereby amended by adding the following sentence immediately following the end of such definition:
  
 "Notwithstanding the foregoing, EBITDA for Holdings and its Subsidiaries on a Consolidated Basis (x) for the fiscal quarter ending on March 31, 2018 shall be deemed to be $2,887,000, (y) for the fiscal quarter ending on June 30, 2018 shall be deemed to be $3,353,000 and (z) for the fiscal quarter ending on September 30, 2018 shall be deemed to be $3,289,000.".
  
 (ii) "Payment Office" is hereby amended and restated in its entirety to read as follows:
  
 ""Payment Office" shall mean the Administrative Agent's office located at MGG Investment Group LP, One Penn Plaza, 53rd Floor, New York, New York 10119, or at such other office or offices of the Administrative Agent as may be designated in writing from time to time by the Administrative Agent to the Collateral Agent and the Borrowing Agent."
  
  	 
	2
	 
 
	 

  
 (c) Section 2.3(c) (Term Loans). The table set forth in Section 2.3(c) of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
  
 	 "Date
	  
	 Principal Payment Required
	  

	 December 31, 2018
	  
	$	1,000,000.00	  

	 March 31, 2019
	  
	$	600,000.00	  

	 June 30, 2019
	  
	$	700,000.00	  

	 September 30, 2019
	  
	$	800,000.00	  

	 December 31, 2019
	  
	$	1,931,944.00	  

	 March 31, 2020
	  
	$	1,931,944.00	  

	 June 30, 2020
	  
	$	2,236,632.00	  

	 September 30, 2020
	  
	$	2,236,632.00	  

	 December 31, 2020
	  
	$	 2,236,632.00”
	  

  
 (d) Section 6.5(a) (Fixed Charge Coverage Ratio). Section 6.5(a) of the Credit Agreement is hereby amended and restated in its entirety as follows:
  
 "(a) Fixed Charge Coverage Ratio. Cause to be maintained as of the last day of each fiscal quarter, a Fixed Charge Coverage Ratio for Holdings and its Subsidiaries on a Consolidated Basis of not less than the amount set forth below opposite such fiscal quarter:
  
 	 Fiscal Quarter Ending
  
	 Minimum Fixed Charge Coverage Ratio
  

	 For the four (4) fiscal quarters ending September 30, 2018
  
	 1.25 to 1.00
  

	 For the fiscal quarter ending December 31, 2018
  
	 0.80 to 1.00
  

	 For the two (2) fiscal quarters ending March 31, 2019
  
	 1.00 to 1.00
  

	 For the three (3) fiscal quarters ending June 30, 2019
  
	 1.05 to 1.00
  

	 For the four (4) fiscal quarters ending September 30, 2019 and for each four (4) fiscal quarter period ending thereafter
  
	 1.05 to 1.00"

  
 (e) Section 6.5(b) (Minimum EBITDA). Section 6.5(b) of the Credit Agreement is hereby amended and restated in its entirety as follows:
  
  	 
	3
	 
 
	 

  
 "(b) Minimum EBITDA. Cause to be maintained as of the last day of each fiscal quarter, EBITDA for Holdings and its Subsidiaries on a Consolidated Basis of not less than the amount set forth below opposite such fiscal quarter, in each case, measured on a trailing four (4) quarter basis:
  
 	 Fiscal Quarter Ending
	  
	 EBITDA
	  

	 September 30, 2018
	  
	$	13,250,000	  

	 December 31, 2018
	  
	$	12,650,000	  

	 March 31, 2019
	  
	$	13,000,000	  

	 June 30, 2019
	  
	$	13,250,000	  

	 September 30, 2019 and each fiscal quarter ending thereafter
	  
	$	 14,000,000"
	  

  
 (f) Section 6.5(c) (Senior Leverage Ratio). Section 6.5(c) of the Credit Agreement is hereby amended and restated in its entirety as follows:
  
 "(c) Senior Leverage Ratio. Cause to be maintained as of the last day of each fiscal quarter, a Senior Leverage Ratio for Holdings and its Subsidiaries on a Consolidated Basis of not greater than the amount set forth below opposite such fiscal quarter, in each case, measured on a trailing four (4) quarter basis:
  
 	 Fiscal Quarter Ending
  
	 Senior Leverage Ratio
  

	 September 30, 2018
	 4.00 to 1.00
  

	 December 31, 2018
	 4.40 to 1.00
  

	 March 31, 2019
	 4.25 to 1.00
  

	 June 30, 2019
	 4.10 to 1.00
  

	 September 30, 2019
	 4.00 to 1.00
  

	 December 31, 2019 and each fiscal quarter ending thereafter 
  
	 2.50 to 1.00"

  
  	 
	4
	 
 
	 

  
 (g) Section 16.6 (Notice). Clause (g)(ii) is hereby amended and restated in its entirety as follows:
  
 "(ii) If to Administrative Agent, Collateral Agent, Term Loan Agent, Issuer, Swing Loan Lender, any Revolving Lender or any Term Loan Lender, to:
  
 MGG Investment Group LP
 One Penn Plaza, 53rd Floor
 New York, New York 10119
 Attention: Kevin F. Griffin
 Telephone: 212-356-6100
 Email: creditagreementnotices@mgginv.com
  
 with a copy to:
  
 Schulte Roth & Zabel LLP
 919 Third Avenue
 New York, NY 10022
 Attention: Frederic L. Ragucci, Esq.
 Telephone: (212) 756-2409
 Facsimile: (212) 593-5955".
  
 3. Limited Waiver. 
  
 (a) Subject to satisfaction of the conditions set forth in Section 5 hereof, and in reliance upon the representations and warranties of Loan Parties set forth herein, the Agents and the Required Lenders hereby waive any Defaults and Events of Default under the Credit Agreement that have solely arisen or would otherwise solely arise under Section 10.5(i) of the Credit Agreement solely by reason of the Loan Parties failing to comply with the financial covenants in Section 6.5 of the Credit Agreement for the period ending September 30, 2018.
  
 (b) The waiver in this Section 3 shall be effective only in this specific instance and for the specific purpose set forth herein and does not allow for any other or further departure from the terms and conditions of the Credit Agreement or any Other Document, which terms and conditions shall continue in full force and effect.
  
  	 
	5
	 
 
	 

  
 4. Representations and Warranties. Each Loan Party hereby represents and warrants to the Agents and the Lenders as follows:
  
 (a) Representations and Warranties; No Event of Default. (i) The representations and warranties herein, in the Credit Agreement and in each Other Document, certificate or other writing delivered by or on behalf of the Loan Parties to any Agent or any Lender pursuant to the Credit Agreement or any Other Document on or prior to the Amendment No. 4 Effective Date are true and correct in all material respects (except that such materiality qualifier shall not be applied to any representations or warranties that already are qualified or modified as to "materiality" or "Material Adverse Effect" in the text thereof, which representations and warranties shall be true and correct in all respects subject to such qualification) on and as of the Amendment No. 4 Effective Date as though made on and as of such date (unless such representations or warranties are stated to relate to an earlier date, in which case such representations and warranties shall be true and correct in all material respects (except that such materiality qualifier shall not be applied to any representations or warranties that already are qualified or modified as to "materiality" or "Material Adverse Effect" in the text thereof, which representations and warranties shall be true and correct in all respects subject to such qualification) on and as of such earlier date), other than (A) the representations and warranties contained in Section 5.5(a) and (b) of the Credit Agreement to the extent that the Pro Forma Balance Sheet and the Projections were prepared in part based on representations and warranties made by the Acquired Companies and/or the SNIH Stockholders (as each such term is defined in the SNI Acquisition Documents) in respect of the balance sheet and the cash flow and balance sheet projections of the Acquired Companies that were not true and correct in all material respects as of the Closing Date and (B) the representations and warranties contained in Section 5.19 of the Credit Agreement that there has been no breach of any material term or condition of the SNI Acquisition Documents to the extent that any representations and warranties made by the Acquired Companies and/or the SNIH Stockholders were not true and correct in all material respects as of the Closing Date, and (ii) no Default or Event of Default has occurred and is continuing as of the Amendment No. 4 Effective Date or would result from this Amendment becoming effective in accordance with its terms.
  
 (b) Organization, Good Standing, Etc. Each Loan Party (i) is a corporation, or limited liability company duly organized, validly existing and in good standing under the laws of the state or jurisdiction of its organization, (ii) has all requisite power and authority to conduct its business as now conducted and as presently contemplated and to execute this Amendment and deliver each Other Document to which it is a party, and to consummate the transactions contemplated hereby and by the Credit Agreement, and (iii) is duly qualified to do business and is in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its business makes such qualification necessary, except (solely for the purposes of this subclause (iii)) where the failure to be so qualified and in good standing could reasonably be expected to have a Material Adverse Effect.
  
 (c) Authorization, Etc. The execution, delivery and performance of this Amendment by the Loan Parties, and the performance of the Credit Agreement, (i) have been duly authorized by all necessary action, (ii) do not and will not contravene (A) any of its Organizational Documents, (B) any material law or regulation, or any judgment, order or decree of any Governmental Body or (C) any Material Contract binding on or otherwise affecting it or any of its properties, (iii) do not and will not result in or require the creation of any Lien (other than pursuant to any Other Document) upon or with respect to any of its properties, and (iv) do not and will not result in any default, noncompliance, suspension, revocation, impairment, forfeiture or nonrenewal of any permit, license, authorization or approval applicable to its operations or any of its properties, except, in the case of clause (iv), to the extent where such contravention, default, noncompliance, suspension, revocation, impairment, forfeiture or nonrenewal could not reasonably be expected to have a Material Adverse Effect.
  
 (d) Governmental Approvals. No authorization or approval or other action by, and no notice to or filing with, any Governmental Body is required in connection with the due execution, delivery and performance by any Loan Party of this Amendment or any Other Document to which it is or will be a party.
  
  	 
	6
	 
 
	 

  
 (e) Enforceability. This Amendment is, and each Other Document to which any Loan Party is or will be a party, when delivered hereunder, will be, a legal, valid and binding obligation of such Person, enforceable against such Person in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors' rights generally and by principles of equity.
  
 5. Conditions to Effectiveness. This Amendment shall become effective only upon satisfaction in full, in a manner satisfactory to the Agents, of the following conditions precedent (the first date upon which all such conditions shall have been satisfied being hereinafter referred to as the "Amendment No. 4 Effective Date"):
  
 (a) Payment of Fees, Etc. The Borrowers shall have paid, on or before the Amendment No. 4 Effective Date, all fees (including the fees of Schulte Roth & Zabel LLP, counsel to the Agents and the Lenders), costs, expenses and taxes then payable pursuant to Article III and Section 16.09 of the Credit Agreement. 
  
 (b) Representations and Warranties. The representations and warranties contained in this Amendment, the Credit Agreement and in each Other Document shall be true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations or warranties that already are qualified or modified as to "materiality" or "Material Adverse Effect" in the text thereof, which representations and warranties shall be true and correct in all respects subject to such qualification) on and as of the Amendment No. 4 Effective Date as though made on and as of such date, (i) except to the extent that any such representation or warranty expressly relates solely to an earlier date (in which case such representation or warranty shall be true and correct on and as of such earlier date) and (ii) other than (A) the representations and warranties contained in Section 5.5(a) and (b) of the Credit Agreement to the extent that the Pro Forma Balance Sheet and the Projections were prepared in part based on representations and warranties made by the Acquired Companies and/or the SNIH Stockholders (as each such term is defined in the SNI Acquisition Documents) in respect of the balance sheet and the cash flow and balance sheet projections of the Acquired Companies that were not true and correct in all material respects as of the Closing Date and (B) the representations and warranties contained in Section 5.19 of the Credit Agreement that there has been no breach of any material term or condition of the SNI Acquisition Documents to the extent that any representations and warranties made by the Acquired Companies and/or the SNIH Stockholders were not true and correct in all material respects as of the Closing Date.
  
 (c) No Default; Event of Default. No Default or Event of Default shall have occurred and be continuing on the Amendment No. 4 Effective Date or result from this Amendment becoming effective in accordance with its terms.
  
 (d) Delivery of Documents. The Agents shall have received on or before the Amendment No. 4 Effective Date this Amendment, duly executed by the Loan Parties, each Agent and each Lender.
  
 (e) Material Adverse Effect. The Agents shall have determined, in their reasonable judgment, that no event or development shall have occurred since September 30, 2018, which could reasonably be expected to have a Material Adverse Effect.
  
 (f) Liens; Priority. The Agents shall be satisfied that the Collateral Agent has been granted, and holds, for the benefit of the Agents and the Lenders, a perfected, first priority Lien on and security interest in all of the Collateral, subject only to Permitted Encumbrances, to the extent such Liens and security interests are required pursuant to the Credit Agreement and the Other Documents to be granted or perfected on or before the Amendment No. 4 Effective Date.
  
  	 
	7
	 
 
	 

  
 (g) Approvals. All consents, authorizations and approvals of, and filings and registrations with, and all other actions in respect of, any Governmental Body or other Person required in connection with the Credit Agreement and any Other Document or the transactions contemplated thereby or the conduct of the Loan Parties' business shall have been obtained or made and shall be in full force and effect. There shall exist no claim, action, suit, investigation, litigation or proceeding (including, without limitation, shareholder or derivative litigation) pending or, to the knowledge of any Loan Party, threatened in any court or before any arbitrator or Governmental Body which (i) relates to the Credit Agreement and the Other Documents or the transactions contemplated thereby or (ii) could reasonably be expected to have a Material Adverse Effect.
  
 6. Continued Effectiveness of the Credit Agreement and Other Documents. Each Loan Party hereby (i) acknowledges and consents to this Amendment, (ii) confirms and agrees that the Credit Agreement and each Other Document to which it is a party is, and shall continue to be, in full force and effect and is hereby ratified and confirmed in all respects except that on and after the Amendment No. 4 Effective Date all references in any such Other Document to "the Credit Agreement", the "Agreement", "thereto", "thereof", "thereunder" or words of like import referring to the Credit Agreement shall mean the Credit Agreement as amended or modified by this Amendment, and (iii) confirms and agrees that to the extent that any such Other Document purports to assign or pledge to the Collateral Agent for the benefit of the Agents and the Lenders, or to grant to the Collateral Agent for the benefit of the Agents and the Lenders a security interest in or Lien on, any Collateral as security for the Obligations of the Loan Parties from time to time existing in respect of the Credit Agreement (as amended hereby) and the Other Documents, such pledge, assignment and/or grant of the security interest or Lien is hereby ratified and confirmed in all respects. This Amendment does not and shall not affect any of the obligations of the Loan Parties, other than as expressly provided herein, including, without limitation, the Loan Parties' obligations to repay the Loans in accordance with the terms of Credit Agreement, or the obligations of the Loan Parties under any Other Document to which they are a party, all of which obligations shall remain in full force and effect. Except as expressly provided herein, the execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of the Agents or any Lender under the Credit Agreement or any Other Document, nor constitute a waiver of any provision of the Credit Agreement or any Other Document.
  
 7. No Novation. Nothing herein contained shall be construed as a substitution or novation of the Obligations outstanding under the Credit Agreement or instruments securing the same, which shall remain in full force and effect, except as modified hereby. 
  
 8. No Representations by Agents or Lenders. Each Loan Party hereby acknowledges that it has not relied on any representation, written or oral, express or implied, by any Agent or any Lender, other than those expressly contained herein, in entering into this Amendment.
  
  	 
	8
	 
 
	 

  
 9. Release. 
  
 (a) Each Loan Party hereby acknowledges and agrees that: (a) neither it nor any of its Affiliates has any claim or cause of action against any Agent or any Lender (or any of their respective Affiliates, officers, directors, employees, attorneys, consultants or agents) under the Credit Agreement and the Other Documents and (b) each Agent and each Lender has heretofore properly performed and satisfied in a timely manner all of its obligations to such Loan Party and its Affiliates under the Credit Agreement and the Other Documents. Notwithstanding the foregoing, the Agents and the Lenders wish (and each Loan Party agrees) to eliminate any possibility that any past conditions, acts, omissions, events or circumstances would impair or otherwise adversely affect any of the Agents' and the Lenders' rights, interests, security and/or remedies under the Credit Agreement and the Other Documents. Accordingly, for and in consideration of the agreements contained in this Amendment and other good and valuable consideration, each Loan Party (for itself and its Affiliates and the successors, assigns, heirs and representatives of each of the foregoing) (collectively, the "Releasors") does hereby fully, finally, unconditionally and irrevocably release and forever discharge each Agent, each Lender and each of their respective Affiliates, officers, directors, employees, attorneys, consultants and agents (collectively, the "Released Parties") from any and all debts, claims, obligations, damages, costs, attorneys' fees, suits, demands, liabilities, actions, proceedings and causes of action, in each case, whether known or unknown, contingent or fixed, direct or indirect, and of whatever nature or description, and whether in law or in equity, under contract, tort, statute or otherwise, which any Releasor has heretofore had or now or hereafter can, shall or may have against any Released Party by reason of any act, omission or thing whatsoever done or omitted to be done on or prior to the Amendment No. 4 Effective Date and arising out of, connected with or related in any way to this Amendment, the Credit Agreement or any Other Document, or any act, event or transaction related or attendant thereto, or the agreements of any Agent or any Lender contained therein, or the possession, use, operation or control of any of the assets of each Loan Party, or the making of any Loans, or the management of such Loans or the Collateral, in each case, on or prior to the Amendment No. 4 Effective Date. 
  
 (b) As to each and every claim released hereunder, each Loan Party hereby represents that it has received the advice of legal counsel with regard to the releases contained herein, and having been so advised, specifically waives the benefit of each provision of applicable federal or state law (including without limitation the laws of the state of New York), if any, pertaining to general releases after having been advised by its legal counsel with respect thereto.
  
 (c) Each Loan Party acknowledges that it may hereafter discover facts different from or in addition to those now known or believed to be true with respect to such claims, demands, or causes of action and agrees that this instrument shall be and remain effective in all respects notwithstanding any such differences or additional facts. Each Loan Party understands, acknowledges and agrees that the release set forth above may be pleaded as a full and complete defense and may be used as a basis for an injunction against any action, suit or other proceeding which may be instituted, prosecuted or attempted in breach of the provisions of such release. 
  
  	 
	9
	 
 
	 

  
 (d) Each Loan Party, for itself and on behalf of its successors, assigns, and officers, directors, employees, agents and attorneys, and any Person acting for or on behalf of, or claiming through it, hereby absolutely, unconditionally and irrevocably, covenants and agrees with and in favor of the Released Parties above that it will not sue (at law, in equity, in any regulatory proceeding or otherwise) the Released Parties on the basis of any claim released, remised and discharged by such Person pursuant to this Section 9. Each Loan Party further agrees that it shall not dispute the validity or enforceability of the Credit Agreement or any of the Other Documents or any of its obligations thereunder, or the validity, priority, enforceability or the extent of Collateral Agent's Lien on any item of Collateral under the Credit Agreement or the Other Documents. If any Loan Party or any of its respective successors, assigns, or officers, directors, employees, agents and attorneys, or any Person acting for or on behalf of, or claiming through it violate the foregoing covenant, such Person, for itself and its successors, assigns and legal representatives, agrees to pay, in addition to such other damages as the Released Parties may sustain as a result of such violation, all reasonable attorneys' fees and costs incurred by the Released Parties as a result of such violation.
  
 10. Further Assurances. The Loan Parties shall execute any and all further documents, agreements and instruments, and take all further actions, as may be required under Applicable Law or as any Agent may reasonably request, in order to effect the purposes of this Amendment.
  
 11. Miscellaneous.
  
 (a) This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of this Amendment by facsimile or electronic mail shall be equally effective as delivery of an original executed counterpart of this Amendment. 
  
 (b) Section and paragraph headings herein are included for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.
  
 (c) This Amendment shall be governed by, and construed in accordance with, the laws of the State of New York.
  
 (d) Each Loan Party hereby acknowledges and agrees that this Amendment constitutes an "Other Document" under the Credit Agreement. Accordingly, it shall be an immediate Event of Default under the Credit Agreement if (i) any representation or warranty made by any Loan Party under or in connection with this Amendment shall have been incorrect in any respect when made or deemed made, or (ii) any Loan Party shall fail to perform or observe any term, covenant or agreement contained in this Amendment.
  
 (e) Any provision of this Amendment that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining portions hereof or affecting the validity or enforceability of such provision in any other jurisdiction.
  
 [Remainder of page intentionally left blank.]
  
  	 
	10
	 
 
	 

  
 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered as of the date set forth on the first page hereof.
  
 	 BORROWERS: 
	 GEE GROUP INC.
  
 By: /s/ Kim Thorpe                                  
 Name: Kim Thorpe
 Title: Senior Vice President and CFO
	  

	  
	  
	  

	  
	 SCRIBE SOLUTIONS INC.
  
 By: /s/ Kim Thorpe                                   
 Name: Kim Thorpe
 Title: Senior Vice President and CFO
	  

	  
	  
	  

	  
	 AGILE RESOURCES, INC.
  
 By: /s/ Kim Thorpe                                    
 Name: Kim Thorpe
 Title: Senior Vice President and CFO
	  

	  
	  
	  

	  
	 ACCESS DATA CONSULTING CORPORATION
  
 By: /s/ Kim Thorpe                                    
 Name: Kim Thorpe
 Title: Senior Vice President and CFO
	  

	  
	  
	  

	  
	 TRIAD PERSONNEL SERVICES, INC.
  
 By: /s/ Kim Thorpe                                     
 Name: Kim Thorpe
 Title: Senior Vice President and CFO
	  

	  
	  
	  

	  
	 TRIAD LOGISTICS, INC.
  
 By: /s/ Kim Thorpe                                            
 Name: Kim Thorpe
 Title: Senior Vice President and CFO
	  

	  
	  
	  

	  
	 PALADIN CONSULTING, INC.
  
 By: /s/ Kim Thorpe                                       
 Name: Kim Thorpe
 Title: Senior Vice President and CFO
	  

  
  	 
	11
	 
 
	 

  
  
 	  
	 BMCH, INC.
  
 By: /s/ Kim Thorpe                                   
 Name: Kim Thorpe
 Title: Senior Vice President and CFO
	  

	  
	  
	  

	  
	 GEE GROUP PORTFOLIO INC.
  
 By: /s/ Kim Thorpe                                   
 Name: Kim Thorpe
 Title: Senior Vice President and CFO
	  

	  
	  
	  

	  
	 SNI COMPANIES
  
 By: /s/ Kim Thorpe                                     
 Name: Kim Thorpe
 Title: Senior Vice President and CFO
	  

  
  	 
	12
	 
 
	 

  
 	 AGENTS:
  
	 MGG INVESTMENT GROUP LP,
 as Administrative Agent, Collateral Agent and Term Loan Agent
  
 By: MGG GP LLC, its general partner
	  

	  
	  
	  

	  
	 By: /s/ Kevin Griffin                                  
 Name: Kevin Griffin
 Title: CEO and CIO
	  

	  
	  
	  

	 LENDERS:
	 MGG SPECIALTY FINANCE FUND LP, as a
 Term Loan Lender and a Revolving Lender
  
 By: MGG Investment Group GP LLC
  
 By: /s/ Kevin Griffin                                    
 Name: Kevin Griffin
 Title: CEO and CIO
	  

  
  	  
	 MGG FUNDING II, LLC, as a
 Term Loan Lender 
  
 By: MGG Investment Group GP LLC
  
 By: /s/ Kevin Griffin                                        
 Name: Kevin Griffin
 Title: CEO and CIO
  
 MGG SF DRAWDOWN UNLEVERED FUND LP, as a Term Loan Lender 
  
 By: MGG Investment Group GP LLC, its general partner
  
 By: /s/ Kevin Griffin                                            
 Name: Kevin Griffin
 Title: CEO and CIO
	  

  
  	 
	13
	 
 
	 

  
 	  
	 MGG SF EVERGREEN UNLEVERED FUND LP, as a Term Loan Lender 
  
 By: MGG Investment Group GP LLC, its general partner
  
 By: /s/ Kevin Griffin                                     
 Name: Kevin Griffin
 Title: CEO and CIO
  
 MGG SF EVERGREEN MASTER FUND (CAYMAN) LP, as a Term Loan Lender
  
 By: MGG Investment Group GP LLC, its general partner
  
 By: /s/ Kevin Griffin                                      
 Name: Kevin Griffin
 Title: CEO and CIO
  
 MGG SF DRAWDOWN MASTER FUND (CAYMAN) LP, as a Term Loan Lender 
  
 By: MGG Investment Group GP II LLC, its general partner
   
 By: /s/ Kevin Griffin                                        
 Name: Kevin Griffin
 Title: CEO and CIO
	  

	  
	  
	  

	  
	 CM FINANCE SPV, LTD., as a Term Loan Lender 
   
 By: /s/ Rocco DelGuercio                               
 Name: Rocco DelGuercio
 Title: Chief Financial Officer & Chief Compliance Officer
	  

  
  	 14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]